CENTER OF MOLECULAR IMMUNOLOGY

Trials shown by sponsor

Public title	Date of Registration	State
EC122 HER-1 Prostate Phase I	15/11/2016	Registered
Dose scale-up and cohort expansion with the therapeutic mAb 14F7	04/12/2015	Registered outdated
Combined NGcGM3/VSSP and Nimotuzumab in advanced non-small cell lung cancer (NSCLC)	30/04/2018	Registered
Clinical trial, phase II: Evaluation of TheraCIM hR3 MaB combined with chemo- and radio-therapy to treat patients with epithelial tumors in neck of the uterus, stage III.	2010-12-27	Registered
CIMAvax-EGF®-post-COVID19 convalescent with respiratory disorders-adults-Phase II (CORVAXCIM)	18/06/2021	Registered outdated
CIMAvax-EGF® in metastatic asymptomatic or mildly symptomatic Castration Resistant Prostate Cancer patients. Phase II-III Clinical Trial	17/10/2018	Registered
CIMAvax-EGF/Lung cancer/Biomarkers/Prospective CT	20/10/2021	Registered
CIMAvax-EGF-Platelets-Adults- Lung Cancer	03/08/2018	Registered
CIMAvax-EGF vaccine Predictor Phase IV	14/12/2015	Registered outdated
CIMAvax-EGF in patients at high risk of lung cancer	22/10/2020	Registered outdated
CIMAvax-EGF in different maintenance schemes	12/05/2021	Registered outdated
CIMAvax-EGF in Bladder cancer	11/08/2020	Registered outdated
CIMAVax EGF in Lung Cancer in PHC. Phase IV	05/08/2014	Registered
CIMAbior® in CD20-positive B-cell Non-Hodgkin Lymphoma	05/09/2017	Registered
Biomodulina T- CIMAvax-EGF-Advanced Non-Small Cell Lung Cancer-Adults	18/03/2021	Registered outdated
Anti-idiotype 1E10 vaccine in the treatment of patients with small cell lung (SCLC) patients	2010-12-28	Registered
Anti-idiotype 1E10 vaccine in advanced non- small cell lung (NSCLC) patients	2010-12-28	Registered
Advanced breast cancer treatment with hR3 monoclonal antibody combined with doxorubicin and cyclophosphamide, phase I.	2010-12-17	Registered
99mTc-marked 14F7 MaB in metastatic breast, phase II	2008-12-27	Registered
99mtc-marked 14f7 MAb in colon/rectum tumor, Phase II	2010-12-17	Registered

Registered Trials

Registration process

CENTER OF MOLECULAR IMMUNOLOGY

About the RPCEC

Useful resources